a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases.
Industry Biotechnology
A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.
Ticker / NAME | Correlation To IMVT | 1D Price Change % | ||
---|---|---|---|---|
IMVT | 100% | +1.01% | ||
ROIV - IMVT | 57% Loosely correlated | +0.41% | ||
ARGX - IMVT | 44% Loosely correlated | +0.90% | ||
GRCE - IMVT | 42% Loosely correlated | +6.59% | ||
CRNX - IMVT | 39% Loosely correlated | +1.35% | ||
SNDX - IMVT | 38% Loosely correlated | -1.16% | ||
More |